Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1990
11/14/1990EP0396626A1 Glycosides, liposomal compositions thereof, and methods for their use
11/14/1990EP0396588A1 Amino anthracenediones-bis platinum complexes, useful as antitumoral agents
11/14/1990EP0262188B1 Steroids comprising a spiranic cycle in position 17, preparation process and utilization thereof
11/14/1990CN1046892A Fluorinated arachidonic acid derivatives
11/14/1990CN1010409B Process for the preparation of n-benzoyl-n'-pyrimidinyloxyphenyl urea compounds and antitumokous compositions containing them
11/13/1990CA1276400C Process for producing (amido)n-substituted bleomycins
11/13/1990CA1276159C Water soluble platinum complexes of novel malonate derivatives
11/13/1990CA1276108C Process for modifying ribosome-inactivating glycoproteins by oxidation of their osidic units and formation of a schiff's base
11/12/1990CA2016439A1 N-phenyl amides, process for their preparation and medicaments containing same
11/12/1990CA2016437A1 Process for the preparation of a new antitumoral substance, amino-3 (amino-2 1h-imidazolyl-4)-1 chloro-2 propanol-1, and of its threo racemic salts, usable as medicaments
11/12/1990CA2016436A1 Antitumoral substance, process for its preparation, and pharmaceutical compositions containing same
11/10/1990CA2016385A1 Tumor-associated antigen, antibodies, compositions and uses therefor
11/07/1990EP0396387A2 A novel antibody delivery system for biological response modifiers
11/07/1990EP0395849A1 [3-(C16-C18)alkane sulfinyl- and sulfonyl-2-methoxymethyl-propyl]-(2-trimethylammonio-ethyl) phosphates, process for their preparation and medicaments containing these
11/07/1990CN1046739A Macrocyclic aminophosphonic acid complexes, their preparation formulations and use
11/06/1990US4968826 Platinum complexes and antitumor agents containing them as an active ingredient
11/06/1990US4968804 Bipyridine compounds
11/06/1990US4968800 Novel platinum complex, antineoplastic agent containing the same, and intermediate therefor
11/06/1990US4968715 Use of purified hematoporphyrin trimers in photodynamic therapy
11/06/1990CA1276032C Polyene compounds
11/06/1990CA1276024C Substituted hydroxy-heterocyclyl-alkoxyphosphinyloxy- trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
11/06/1990CA1275951C Lysing or blocking unwanted cells
11/05/1990WO1990013568A1 Antimetastatic peptides
11/05/1990CA2030798A1 Antimetastatic peptides
11/04/1990CA2015862A1 Cell surface antigen that binds with l6 monoclonal antibody
11/03/1990WO1990013530A1 Preparation of rhenium phosphonate therapeutic agents
11/03/1990CA2064063A1 Preparation of rhenium phosphonate therapeutic agents
11/01/1990WO1990012885A1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same
11/01/1990WO1990012594A1 Novel monoclonal antibody to novel antigen associated with human tumors
11/01/1990WO1990012573A1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy
11/01/1990WO1990009170A3 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation
10/1990
10/31/1990EP0394983A2 Anthracycline derivatives with cytostatic activity
10/31/1990EP0394982A2 Anthracycline derivatives with cytostatic activity
10/31/1990EP0394908A1 Process for producing glucosaminyl-epi-podophyllotoxin derivatives
10/31/1990EP0394907A1 Process for producing etoposides
10/31/1990EP0394542A1 Bone marrow cell recovery with synthetic csf inducers
10/31/1990EP0394429A1 Preparation for transdermal application containing gestodene.
10/31/1990EP0394277A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
10/31/1990EP0394265A1 Method for size separation of particles.
10/31/1990CN1046527A Aromatase inhibiting 4(5)- imidazoles
10/30/1990US4966999 Phenolic hydrazides, hydrazines and amines; antibody conju-gates for diagnosis and therapy
10/30/1990US4966971 Reduction, hydrolysis, cyclization of acetal compound
10/30/1990US4966964 Inhibitors of angiogenin
10/30/1990US4966891 Fluorocytidine derivatives
10/29/1990WO1990013293A1 Cytochalasin compositions and therapeutic methods
10/29/1990WO1990013291A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours
10/29/1990CA2050936A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours
10/29/1990CA2031520A1 Cytochalasin compositions and therapeutic methods
10/28/1990WO1990012597A1 Fibroblast growth factor conjugates
10/26/1990CA2015398A1 Rhodomycin derivatives with cytostatic activity
10/26/1990CA2015395A1 Rhodomycin derivatives with cytostatic activity
10/26/1990CA2010886A1 Cell growth inhibitory macrocyclic lactones denominated combretastatin d-1 and combretastatin d-2
10/25/1990DE3913438A1 Verfahren zum herstellen einer immunitaetsgedaechtniszellsuspension A method of manufacturing a immunitaetsgedaechtniszellsuspension
10/24/1990EP0393973A1 Antitumor Agent Indicated for lung cancer
10/24/1990EP0393883A1 Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
10/24/1990EP0393575A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent
10/24/1990EP0386146A4 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
10/24/1990EP0325639A4 Fibrin-binding compound and method
10/24/1990CN1046333A Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing methyle-trithio group, and targeted forms thereof
10/23/1990US4965357 2,5,6-substituted N1 -alkylpyrimidines
10/23/1990US4965352 Anthracycline derivatives having cytostatic activity
10/23/1990US4965351 Intermediates for antitumor agents
10/23/1990US4965348 Antitumor agents
10/23/1990US4965347 Beta-D-glucan, and its production and uses
10/23/1990US4965075 Administering (dihomo)gammalinoleic acid and copper compound
10/23/1990US4965064 Cancer diagnosis
10/23/1990CA1275452C2 Drug, and methods of preparing and using it for treatment of tumors
10/23/1990CA1275406C Process for production of anthracycline compound r20x2
10/22/1990CA2015074A1 Process for the preparation of etoposides
10/22/1990CA2015072A1 Process for the preparation of glucosaminyl-epi-podophyllotoxin derivatives
10/18/1990WO1990012091A1 Urokinase-type plasminogen activator receptor
10/18/1990WO1990011766A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/18/1990WO1990011764A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
10/18/1990WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
10/18/1990WO1990010639A3 New 3'-(4-morpholinyl)- and 3'-(2-methoxy-4-morpholinyl)- anthracycline derivatives
10/18/1990EP0415924A4 Regulation of cell proliferation and differentiation using peptides.
10/18/1990CA2014679A1 Antitumor agent indicated for lung cancer
10/17/1990EP0392913A1 (3-Diethylaminopropyl)-1-amino-5-methyldipyrido [4,3-b] [3,4-f] indole trihydrochloride
10/17/1990EP0392745A2 Immunoconjugates and prodrugs and their use in association for drug delivery
10/17/1990EP0392717A1 Pharmaceutical formulations containing immunoglobulin conjugates
10/17/1990EP0392662A2 Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents
10/17/1990EP0392384A2 Targeted forms of methyltrithio antitumor agents
10/17/1990EP0392376A2 N-acyl derivatives of the LL-E33288 antitumor antibiotics
10/17/1990EP0392300A1 Use of at least one cytokin for the manufacture of a medicament for the systemic treatment of preneoplastic lesions
10/17/1990EP0391962A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine
10/17/1990EP0391957A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu?17 -VIP-ANALOGS AND NEW Leu?17 -VIP-ANALOGS
10/17/1990EP0391953A1 Common acute lymphoblastic leukemia antigen
10/17/1990CA2014732A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent
10/17/1990CA2014304A1 Monoclonal antibody to novel anitgen associated with human tumors
10/16/1990US4963681 Heating anhydrous mixture of amine, alkyl phosphite ester, phosphonate acetal ester; adding water
10/16/1990US4963588 Use of ubenimex for treating myelodysplastic syndrome
10/16/1990US4963581 Prevention or treatment of breast cancer; inhibitor of aromatase, lowering estrogen level
10/16/1990US4963559 Method of treating cancer and cancer metastasis
10/16/1990US4963363 Phospholipid delivery vehicle for aqueous-insoluble active ingredients
10/16/1990US4963358 Culturing human malignant tumor cells then extracting cells from medium
10/16/1990CA1275249C Composition containing essential fatty acids
10/13/1990CA2014375A1 Compounds
10/11/1990WO1990012585A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
10/11/1990CA2028825A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
10/11/1990CA2014130A1 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions
1 ... 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 ... 2211